Tue, Sep 2, 2014, 3:36 AM EDT - U.S. Markets open in 5 hrs 54 mins


% | $
Quotes you view appear here for quick access.

Hyperion Therapeutics, Inc. (HPTX) Message Board

  • rrtzrealmd rrtzrealmd May 1, 2013 12:19 PM Flag

    Well, wasn't that cheeky?...

    ...I saw $20.15 cross the tape!...I guess at least someone's getting nervous!...next thing you know you'll see the beginning of the stream of meaningless press releases -- just like OMER's been doing -- to try and prop the price up...fortunately, the street -- as demonstrated by OMER's miserable failure -- has wised up to such nonsense...

    ...now the question is where will HPTX find support -- 20, 15, 10, 5, or maybe even lower!...

    ...and when you consider the customer base:

    "We estimate that the number of individuals in the United States with UCD is approximately 2,100, of which approximately 1,100 are currently diagnosed and approximately 425 are treated with BUPHENYL, and 90 are treated with Ravicti. Of these, we estimate that approximately 60% are children and 40% are adults."

    ...wow!...just think!...your company depends upon all of five HUNDRED customers -- most of whom depend on MEDICAID to pay for their therapy!...now that oughta produce soom BOOMIN' sales figures!...

    ....more ESPECIALLY after HPTX announces that the FDA will require a separate 510k approval for the urinary phenylacetylglutamine test that is REQUIRED to monitor appropriate dosages of the drug...and since HPTX doesn't do the test themselves, they will have to find some lab willing to undertake the onerous task of gaining approval even thought the lab itself might never see revenues from the test...

    ...oh, yes, that little announcement will certainly take a lot of the wind out of HPTX's sails, I should think!...

    ...don't you agree?...HAW, HAW, HAW!!!!....

    Sentiment: Strong Sell

25.86+0.70(+2.78%)Aug 29 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Exelixis, Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT
Splunk, Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT